1.655
Precedente Chiudi:
$1.70
Aprire:
$1.7
Volume 24 ore:
188.85K
Relative Volume:
0.16
Capitalizzazione di mercato:
$101.59M
Reddito:
$5.03M
Utile/perdita netta:
$-185.41M
Rapporto P/E:
-0.5356
EPS:
-3.09
Flusso di cassa netto:
$-139.79M
1 W Prestazione:
+13.36%
1M Prestazione:
+31.35%
6M Prestazione:
-86.81%
1 anno Prestazione:
-87.19%
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Nome
Pliant Therapeutics Inc
Settore
Industria
Telefono
650-481-6770
Indirizzo
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Confronta PLRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PLRX
Pliant Therapeutics Inc
|
1.655 | 96.99M | 5.03M | -185.41M | -139.79M | -3.09 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
388.96 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.87 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
425.78 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
689.78 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.50 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-04 | Ripresa | Cantor Fitzgerald | Neutral |
2025-03-04 | Downgrade | Needham | Buy → Hold |
2025-03-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
2025-03-03 | Downgrade | Stifel | Buy → Hold |
2025-02-10 | Downgrade | Canaccord Genuity | Buy → Hold |
2025-02-10 | Downgrade | Citigroup | Buy → Neutral |
2025-02-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
2025-02-10 | Downgrade | JP Morgan | Overweight → Neutral |
2025-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
2025-02-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2025-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-09-09 | Ripresa | Leerink Partners | Outperform |
2023-12-08 | Iniziato | Wells Fargo | Overweight |
2023-05-18 | Iniziato | Canaccord Genuity | Buy |
2023-04-13 | Iniziato | Robert W. Baird | Outperform |
2022-12-14 | Iniziato | Stifel | Buy |
2022-12-07 | Iniziato | JP Morgan | Overweight |
2022-09-01 | Iniziato | Citigroup | Buy |
2022-07-20 | Iniziato | SVB Leerink | Outperform |
2022-05-25 | Iniziato | Cantor Fitzgerald | Overweight |
2021-12-10 | Iniziato | Oppenheimer | Outperform |
2021-11-24 | Iniziato | RBC Capital Mkts | Outperform |
2021-11-03 | Iniziato | H.C. Wainwright | Buy |
2021-04-20 | Iniziato | BTIG Research | Buy |
2021-04-05 | Iniziato | Citigroup | Buy |
2020-06-29 | Iniziato | Citigroup | Buy |
2020-06-29 | Iniziato | Cowen | Outperform |
2020-06-29 | Iniziato | Needham | Buy |
2020-06-29 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie
Should I hold or sell Pliant Therapeutics Inc. stock in 2025Tremendous financial leverage - Jammu Links News
Pliant Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - Jammu Links News
How many analysts rate Pliant Therapeutics Inc. as a “Buy”Identify undervalued stocks ready to soar - Jammu Links News
A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $3 to $17 - 富途牛牛
How volatile is Pliant Therapeutics Inc. stock compared to the marketDiscover hidden gems in the stock market - Jammu Links News
How does Pliant Therapeutics Inc. compare to its industry peersInvest confidently with market-leading analysis - Jammu Links News
Is Pliant Therapeutics Inc. a good long term investmentInvest confidently with expert support - Jammu Links News
Does Pliant Therapeutics Inc. stock perform well during market downturnsAchieve rapid portfolio growth with expert guidance - Jammu Links News
What is the risk reward ratio of investing in Pliant Therapeutics Inc. stockGame-changing returns - Jammu Links News
What makes Pliant Therapeutics Inc. stock price move sharplyFree Stock Market Return Analysis - Jammu Links News
What are Pliant Therapeutics Inc. company’s key revenue driversDiscover undervalued opportunities early - Jammu Links News
What is Pliant Therapeutics Inc. company’s growth strategyBuild wealth steadily with smart stock selection - Jammu Links News
Pliant Therapeutics Inc. Trading Near Value Zone — Recovery AheadTop Performing Stock Insights Released Daily - metal.it
What are analysts’ price targets for Pliant Therapeutics Inc. in the next 12 monthsAdvanced Screener Planner For 2025 - Jammu Links News
Competitive Positioning of Pliant Therapeutics Inc.: Is It Leading or LaggingWeekly Return Pick Forecast Reports Show Trend - metal.it
Bollinger Bands Expand on Pliant Therapeutics Inc. — Volatility AheadWatchlist for Smart Swing Trading Updated - beatles.ru
Will Pliant Therapeutics Inc. stock split in the near futureInvestment Playbook for Growing Markets Shared - metal.it
Pliant Therapeutics Inc. Sees Spike in Bullish Option FlowDaily Momentum Screener With Alerts Launched - metal.it
What catalysts could drive Pliant Therapeutics Inc. stock higher in 2025Unprecedented profit potential - Jammu Links News
Pliant Therapeutics Inc. Added to High Probability Setup ListLow Risk High Return Opportunities Identified - metal.it
What is the dividend policy of Pliant Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News
Is it the right time to buy Pliant Therapeutics Inc. stockHigh-octane financial growth - jammulinksnews.com
Pliant Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Stock Market Practical Discussion Forums - beatles.ru
What drives Pliant Therapeutics Inc. stock priceExplosive trading opportunities - PrintWeekIndia
How high can Pliant Therapeutics Inc. stock price go in 2025Explosive wealth accumulation - jammulinksnews.com
What analysts say about Pliant Therapeutics Inc. stockOutperformance with explosive growth - Jammu Links News
Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):